Charles River Laboratories International Inc 's Cash & cash equivalent grew by 4.35 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Charles River Laboratories International Inc 's Quick Ratio to 0.18, Quick Ratio remained below Charles River Laboratories International inc average.

Within Medical Laboratories industry 31 other companies have achieved higher Quick Ratio than Charles River Laboratories International Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 3407, from total ranking in the second quarter 2026 at 4134.

Explain Quick Ratio?
How much Cash & cash equivalents CRL�s has?
What are CRL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CRL/financial-strength

https://api.csimarket.com/api/v1/companies/CRL/fundamentals

https://api.csimarket.com/api/v1/companies/CRL/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CRL Quick Ratio	(Sep 26 2026) Q3	(Jun 27 2026) Q2	(Mar 28 2026) Q1	(Dec 27 2025) Q4	(Sep 27 2025) Q3
Y / Y Current Liabilities Change	23.2 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-3.24 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.18	Subscribe	Subscribe	Subscribe	Subscribe
CRL's Total Ranking	# 3407	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-4.01 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	4.35 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Laboratories Industry	# 32
Healthcare Sector	# 830
Overall Market	# 3456

Quick Ratio Statistics
High	Average	Low
1.23	0.41	0.17
(Jun 26 2010)		(Jun 27 2026)

Financial Statements
Charles River Laboratories International Inc 's Current Liabilities	$ 1,089 Millions	Visit CRL's Balance sheet
Charles River Laboratories International Inc 's Cash & cash equivalent	$ 200 Millions	Visit CRL's Balance sheet
Source of CRL's Sales		Visit CRL's Sales by Geography

Cumulative Charles River Laboratories International Inc 's Quick Ratio

CRL's Quick Ratio for the trailling 12 Months

CRL Quick Ratio	(Sep 26 2026) 12 Months	(Jun 27 2026) 12 Months	(Mar 28 2026) 12 Months	(Dec 27 2025) 12 Months	(Sep 27 2025) 12 Months
Y / Y Current Liabilities TTM Growth	25.59 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-1.95 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.2	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4094	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	5.3 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-0.83 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CRL Financial Strength Comparisons >> Go to Compare CRL Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $1,089.26 millions, cumulative Quick Ratio decreased to 0.2 below the Charles River Laboratories International Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 36 other companies have achieved higher Quick Ratio than Charles River Laboratories International Inc . While Quick Ratio overall ranking has improved so far to 4094, from total ranking during the twelve months ending second quarter 2026 at 4098.

Explain Quick Ratio?
How much Cash & cash equivalents CRL�s has?
What are CRL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 37
Healthcare Sector	# 909
Within the Market	# 4094

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.6	0.33	0.18
(Mar 29 2014)		(Jun 27 2026)

Companies with similar Quick Ratio in the quarter ending Sep 26 2026, within Medical Laboratories Industry	Quick Ratio	Sep 26 2026 MRQ Cash & cash equivalent	Sep 26 2026 MRQ Current Liabilities
Quest Diagnostics Inc	0.49	$ 893.000 Millions	$ 1,834.000 Millions
Medpace Holdings Inc	0.47	$ 705.315 Millions	$ 1,496.097 Millions
Ge Healthcare Technologies Inc	0.32	$ 2,826.000 Millions	$ 8,815.000 Millions
Grail Inc	0.31	$ 29.394 Millions	$ 94.332 Millions
Iqvia Holdings Inc	0.31	$ 2,422.000 Millions	$ 7,777.000 Millions
Fortrea Holdings Inc	0.22	$ 220.600 Millions	$ 983.300 Millions
Charles River Laboratories International inc	0.18	$ 200.381 Millions	$ 1,089.258 Millions
Labcorp Holdings Inc	0.09	$ 261.800 Millions	$ 2,819.600 Millions
Nrc Health	0.09	$ 3.626 Millions	$ 41.845 Millions

Date modified: 2026-11-05T14:33:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.